
IAG Capital Partners
Description
IAG Capital Partners is a private equity firm based in Charleston, South Carolina, specializing in providing growth capital to established companies. Founded in 2004, the firm focuses on businesses that demonstrate strong management teams, disruptive technologies, and significant market opportunities. Their investment strategy is geared towards supporting companies poised for accelerated growth, market expansion, or strategic acquisitions, positioning them as a key financial partner for scaling enterprises.
The firm primarily targets growth-stage companies with annual revenues typically ranging between $5 million and $50 million. While IAG Capital Partners maintains a sector-agnostic approach, they express a strong interest in specific industries, including technology, healthcare, and business services. This broad yet focused strategy allows them to identify and capitalize on promising ventures across diverse economic sectors, seeking out companies that have achieved a certain level of commercial traction and are ready for their next phase of development.
IAG Capital Partners typically deploys first cheques ranging from $5 million to $25 million, aiming to provide substantial capital injections that can drive significant operational and strategic initiatives. These investments are designed to fund various growth-oriented activities, such as product development, market penetration, geographic expansion, or synergistic mergers and acquisitions. The firm emphasizes a collaborative approach, working closely with portfolio companies to leverage their expertise and network, thereby fostering sustainable value creation and long-term success.
Investor Profile
IAG Capital Partners has backed more than 55 startups, with 14 new investments in the last 12 months alone. The firm has led 21 rounds, about 38% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Ireland, Belgium.
- Strong thematic focus on Biotechnology, Health Care, Artificial Intelligence (AI).
- Led 5 rounds in the past year.
- Typical check size: $5M – $25M.
Stage Focus
- Series B (25%)
- Series A (25%)
- Seed (22%)
- Series Unknown (11%)
- Series C (9%)
- Pre Seed (2%)
- Series H (2%)
- Convertible Note (2%)
- Series D (2%)
Country Focus
- United States (87%)
- Ireland (4%)
- Belgium (4%)
- United Kingdom (2%)
- Spain (2%)
- Canada (2%)
Industry Focus
- Biotechnology
- Health Care
- Artificial Intelligence (Ai)
- Information Technology
- Software
- Medical Device
- Semiconductor
- Machine Learning
- Saas
- Health Diagnostics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.